Mylan Announces Tentative Approval For Venlafaxine Hydrochloride Tablets
Sunday, July 13th, 2008Mylan Laboratories Inc. (NYSE: MYL) announced that the U.S. Food and Drug Administration have granted tentative esteem all for Mylan Pharmaceuticals Inc.’s Abbreviated New Drug Application for Venlafaxine Hydrochloride Tablets 25 mg (base), 37.5 mg (base), 50 mg (base), 75 mg (base) and 100 mg (base).
Ranitidine Syrup, the generic alike of [...]
